Primary prevention of severe lower respiratory illnesses in at-risk infants using the immunomodulator OM-85

Journal of Allergy and Clinical Immunology

Volumn 144, Issue 3, 2019, Pages 870-872.e11

  Sly, Peter D ^a   Galbraith, Sally ^a   Islam, Zahir ^a   Holt, Barbara ^b   Troy, Niamh ^b   Holt, Patrick G ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LYSATE; PLACEBO; BRONCHO-VAXOM; CELL EXTRACT; IMMUNOLOGICAL ADJUVANT;

ARTICLE; DEMOGRAPHY; EAR INFECTION; FEVER; FOLLOW UP; GASTROINTESTINAL DISEASE; GENERAL ASPECTS OF DISEASE; HUMAN; INFANT; LOWER RESPIRATORY TRACT INFECTION; PATIENT RISK; PRIMARY PREVENTION; PRIORITY JOURNAL; SEVERE LOWER RESPIRATORY ILLNESSES; SKIN DISEASE; WHEEZING; WINTER; CONTROLLED STUDY; FEMALE; MALE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION;

ADJUVANTS, IMMUNOLOGIC; CELL EXTRACTS; FEMALE; HUMANS; INFANT; MALE; PRIMARY PREVENTION; RESPIRATORY TRACT INFECTIONS;

EID: 85067662799     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2019.05.032     Document Type: Article

References (12)

1. Jackson, D.J., Gangnon, R.E., Evans, M.D., Roberg, K.A., Anderson, E.L., Pappas, T.E., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 178 (2008), 667–672.
2. Jackson, D.J., Gern, J.E., Lemanske, R.F., The contributions of allergic sensitization and respiratory pathogens to asthma inception. J Allergy Clin Immunol 137 (2016), 659–665.
3. Kusel, M.M., de Klerk, N.H., Kebadze, T., Vohma, V., Holt, P.G., Johnston, S.L., et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 119 (2007), 1105–1110.
4. Kusel, M.M., Kebadze, T., Johnston, S.L., Holt, P.G., Sly, P.D., Febrile respiratory illnesses in infancy and atopy are risk factors for persistent asthma and wheeze. Eur Respir J 39 (2012), 876–882.
5. Teo, S.M., Mok, D., Pham, K., Kusel, M., Serralha, M., Troy, N., et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe 17 (2015), 704–715.
6. Holt, P.G., Sly, P.D., Infections and atopy in asthma pathogenesis: the hygiene hypothesis and beyond. Nat Med 18 (2012), 726–735.
7. Schaad, U.B., Mutterlein, R., Goffin, H., Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study. Chest 122 (2002), 2042–2049.
8. Razi, C.H., Harmanci, K., Abaci, A., Ozdemir, O., Hizli, S., Resida, R., et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol 126 (2010), 763–769.
9. Scott, N.M., Lauzon-Joset, J.F., Jones, A.C., Minchin, K.T., Troy, N.M., Leffler, J., et al. Protection against maternal infection-associated fetal growth restriction: proof-of-concept with a microbial-derived immunomodulator. Mucosal Immunol 10 (2017), 789–801.
10. Kusel, M.M., Kebadze, T., Johnston, S.L., Holt, P.G., Sly, P.D., Febrile respiratory illnesses in infancy & atopy are risk factors for persistent asthma & wheeze. Eur Respir J 39 (2012), 876–882.
11. Kusel, M.M., de Klerk, N.H., Kebadze, T., Vohma, V., Holt, P.G., Johnston, S.L., et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 119 (2007), 1105–1110.
12. Razi, C.H., Harmanci, K., Abaci, A., Ozdemir, O., Hizli, S., Resida, R., et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol 126 (2010), 763–769.